Inovio Pharmaceuticals INO
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 1.74 | 24 | 4 | 5.24 | 74 | |
| 2025Q3 | 2.34 | -8 | -45 | -66.12 | 69 | |
| 2025Q2 | 2.04 | 29 | -58.96 | -24 | -30.25 | 68 |
| 2025Q1 | 1.63 | 51 | -32.89 | -20 | -19.65 | 87 |
| 2024Q4 | 1.83 | 69 | -27.29 | -19 | -17.60 | 113 |
| 2024Q3 | 5.78 | 74 | -29.56 | -25 | -20.90 | 107 |
| 2024Q2 | 8.08 | 97 | -33.72 | -32 | -24.52 | 134 |
| 2024Q1 | 13.88 | 94 | -28.77 | -30 | -20.31 | 129 |
| 2023Q4 | 6.12 | 117 | -19.57 | -25 | -13.74 | 171 |
| 2023Q3 | 4.67 | 138 | -22.07 | -34 | -15.92 | 193 |
| 2023Q2 | 5.36 | 169 | -19.28 | -36 | -14.22 | 233 |
| 2023Q1 | 9.84 | 199 | -19.28 | -41 | -13.22 | 267 |
| 2022Q4 | 18.72 | 222 | -22.27 | -54 | -14.71 | 349 |
| 2022Q3 | 20.70 | 267 | -13.39 | -38 | -8.88 | 392 |
| 2022Q2 | 20.76 | 298 | -33.24 | -108 | -23.98 | 459 |
| 2022Q1 | 43.08 | 355 | -20.95 | -79 | -16.80 | 446 |
| 2021Q4 | 59.88 | 400 | -25.07 | -107 | -20.73 | 496 |
| 2021Q3 | 85.92 | 454 | -12.51 | -60 | -10.67 | 536 |
| 2021Q2 | 111.24 | 509 | -15.07 | -82 | -13.18 | 592 |
| 2021Q1 | 111.36 | 582 | -10.43 | -54 | -9.11 | 655 |